Publications by authors named "N Lahlaidi Sierra"

Molecular studies of animal regeneration typically focus on conserved genes and signaling pathways that underlie morphogenesis. To date, a holistic analysis of gene expression across animals has not been attempted, as it presents a suite of problems related to differences in experimental design and gene homology. By combining orthology analyses with a novel statistical method for testing gene enrichment across large data sets, we are able to test whether tissue regeneration across animals shares transcriptional regulation.

View Article and Find Full Text PDF

Mutations in human isocitrate dehydrogenase 1 (IDH1) drive tumor formation in a variety of cancers by replacing its conventional activity with a neomorphic activity that generates an oncometabolite. Little is understood of the mechanistic differences among tumor-driving IDH1 mutants. We previously reported that the R132Q mutant unusually preserves conventional activity while catalyzing robust oncometabolite production, allowing an opportunity to compare these reaction mechanisms within a single active site.

View Article and Find Full Text PDF
Article Synopsis
  • The European Mortality Monitoring Network (EuroMOMO) noticed more people are dying than usual since late November 2023.
  • In the early weeks of 2024, there were about 95 extra deaths for every 100,000 people in Europe, mostly affecting adults aged 45 and older.
  • This rise in deaths seems to be happening because of a lot of illnesses like COVID-19, flu, and RSV during the winter season.
View Article and Find Full Text PDF

Purpose: International cleft lip and palate surgical charities recognize that speech therapy is essential for successful care of individuals after palate repair. The challenge is how to ensure that cleft speech interventionists (i.e.

View Article and Find Full Text PDF

Mutations in human isocitrate dehydrogenase 1 (IDH1) drive tumor formation in a variety of cancers by replacing its conventional activity with a neomorphic activity that generates an oncometabolite. Little is understood of the mechanistic differences among tumor-driving IDH1 mutants. We previously reported that the R132Q mutant uniquely preserves conventional activity while catalyzing robust oncometabolite production, allowing an opportunity to compare these reaction mechanisms within a single active site.

View Article and Find Full Text PDF